货号:A217757
同义名:
HOE-642 Free Base; HOE 642
Cariporide是一种选择性Na+/H+交换体异构体1(NHE1)抑制剂,IC50值为0.05 μM,具有心脏保护和抗心律失常作用。


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 产品名称 | Sodium Channel ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tolperisone HCl | ✔ | 99% | |||||||||||||||||
| Triamterene |
+++
ENaC, IC50: 4.5 μM |
98% | |||||||||||||||||
| Lamotrigine | ✔ | 98% | |||||||||||||||||
| Vinpocetine | ✔ | 98% | |||||||||||||||||
| Zonisamide | ✔ | 99% | |||||||||||||||||
| Dronedarone HCl | ✔ | 95% | |||||||||||||||||
| Procainamide HCl | ✔ | 99% | |||||||||||||||||
| Bupivacaine HCl | ✔ | 99+% | |||||||||||||||||
| Benzocaine | ✔ | 98% | |||||||||||||||||
| Carbamazepine |
++
Sodium channel, IC50: 131 μM |
98% | |||||||||||||||||
| Quinidine sulfate dihydrate | ✔ | 98% | |||||||||||||||||
| Ibutilide fumarate | ✔ | 99%+ | |||||||||||||||||
| Dibucaine HCl | ✔ | 99+% | |||||||||||||||||
| Mexiletine HCl | ✔ | 99% | |||||||||||||||||
| Phenytoin | ✔ | 99+% | |||||||||||||||||
| Camostat Mesylate |
+++
epithelial sodium channel (ENaC), IC50: 50 nM |
99%+ | |||||||||||||||||
| Levobupivacaine | ✔ | 97+% | |||||||||||||||||
| Oxcarbazepine |
+
sodium channel, IC50: 160 μM |
98% | |||||||||||||||||
| Amiloride HCl dihydrate | ✔ | 97% | |||||||||||||||||
| Ambroxol | 98+% | ||||||||||||||||||
| Primidone | ✔ | 99% | |||||||||||||||||
| Propafenone | ✔ | 99% | |||||||||||||||||
| A-803467 |
++++
Na(V1.8) channel, IC50: 8 nM |
99%+ | |||||||||||||||||
| Rufinamide | ✔ | 99% | |||||||||||||||||
| Phenytoin sodium | ✔ | 98% | |||||||||||||||||
| Proparacaine HCl |
+
Voltage-gated sodium channel, ED50: 3.4 mM |
98+% | |||||||||||||||||
| Amiloride HCl | ✔ | 98% | |||||||||||||||||
| Riluzole | ✔ | 97% | |||||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| 描述 | Cariporide remarkably suppressed cytosolic Na+ and Ca2+ accumulation. Mitochondrial Ca2+ overload induced by H2O2 was remarkably suppressed by cariporide. Cariporide prevented mitochondrial membrane potential loss induced by H2O2. Cariporide protects cardiomyocytes against oxidant-induced cell death by preserving intracellular ion homeostasis and mitochondrial integrity[3]. Cariporide (HOE-642) ameliorates myocardial ischemia/reperfusion injury, by the well-established reduction of cytosolic Ca2+ in cardiac myocytes through inhibition of Na+/H+ exchange[4]. Cariporide might inhibit HG-mediated monocyte-endothelial cell adhesion and expression of ICAM-1 (intercellular adhesion molecule-1) by inhibiting the activation of NHE-1(Na(+)/H(+) exchanger 1)[5]. Moreover, cariporide significantly facilitates the sensitivity of breast cancer to doxorubicin both in vitro and in vivo[6]. |
| Concentration | Treated Time | Description | References | |
| HCT116 cells | 1 μM and 10 μM | EMPA did not inhibit the activity of the human NHE1 isoform. | Cardiovasc Res. 2021 Dec 17;117(14):2794-2806. | |
| rat ventricular cardiomyocytes | 10 μM | Cariporide nearly completely inhibited NHE1 activity, while EMPA (1, 3, 10, or 30 μM) showed no NHE1 inhibition. | Cardiovasc Res. 2021 Dec 17;117(14):2794-2806. | |
| human atrial cardiomyocytes | 10 µM | 45 min | Cariporide significantly reduced Na influx in atrial cardiomyocytes of HFpEF patients. | Cardiovasc Res. 2024 Jul 31;120(9):999-1010. |
| rat ventricular cardiomyocytes | 10 μM | Cariporide nearly completely inhibited NHE1 activity | Cardiovasc Res. 2021 Dec 17;117(14):2794-2806. | |
| cardiomyocytes | 10 µM | 5 min | measure NHE1 activity, Cariporide inhibited NHE1 activity | Basic Res Cardiol. 2024 Oct;119(5):751-772. |
| Administration | Dosage | Frequency | Description | References | ||
| Rats, mice, and guinea pigs | Langendorff-perfused hearts | Perfusion | 10 μM | 15 minutes | Cariporide significantly inhibited pH i recovery, while EMPA did not affect [Na+]i or pH i recovery. | Cardiovasc Res. 2021 Dec 17;117(14):2794-2806. |
| Rats | Langendorff-perfused hearts | Perfusion | 10 μM | 15 minutes | Cariporide significantly inhibited pH recovery and [Na+]i rise | Cardiovasc Res. 2021 Dec 17;117(14):2794-2806. |
| Mice | TAC/DOCA-induced heart failure model | Oral | 600 mg/kg | Once daily for 10-12 days | Cariporide mimicked EMPA's protection, preventing the development of heart failure | Basic Res Cardiol. 2024 Oct;119(5):751-772. |
| Mice | Type 2 diabetic dbb mice | Perfusion | 1 μM | Administered 10 minutes before inducing ischemia and remained throughout the experiment | To investigate the role of NHE in cytoplasmic Ca2+ overload and ischemic myocardial damage during ischemia-reperfusion in type 2 diabetic mouse hearts. Results showed that Cariporide significantly reduced Ca2+ overload during ischemia-reperfusion and improved the recovery of ventricular function in diabetic hearts. | Cardiovasc Diabetol. 2012 Apr 11;11:33 |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
3.53mL 0.71mL 0.35mL |
17.65mL 3.53mL 1.76mL |
35.29mL 7.06mL 3.53mL |
|
| CAS号 | 159138-80-4 |
| 分子式 | C12H17N3O3S |
| 分子量 | 283.35 |
| SMILES Code | CS(C1=CC(C(N=C(N)N)=O)=CC=C1C(C)C)(=O)=O |
| MDL No. | MFCD00864683 |
| 别名 | HOE-642 Free Base; HOE 642 |
| 运输 | 蓝冰 |
| InChI Key | IWXNYAIICFKCTM-UHFFFAOYSA-N |
| Pubchem ID | 151172 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Keep in dark place, sealed in dry, 2-8°C |
| 溶解方案 |
DMSO: 105 mg/mL(370.57 mM),注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1